Message from the Organizing Committee of the International Workshop on Liver and Gut Fibrosis in light of the current COVID-19 crisis: 

Due to the current COVID-19 pandemic we feel we have no choice but to postpone the International Workshop on Liver and Gut Fibrosis, which was scheduled to take place 18th-19th June 2020 in Valencia, Spain.

We are currently considering alternative dates for the workshop, which will take place in Valencia at the same venue, and will publish them here on the website as soon as possible.

Registrations will be maintained, while a full refund will be provided to those who request it.

We look forward to seeing you in the not-to-distant future. In the meantime, our thoughts and best wishes go out to patients and their families and to the brave healthcare professionals struggling to contain the pandemic across the globe. 

           

Prof. Juan V. Esplugues

Head of the
Scientific Committee

www.pharmacologyvalencia.com  

 


 

 

 

 

 

 

 

 

 

       

Fibrosis is a global health problem characterized by an excessive growth of fibrous tissue due to chronic inflammation and altered tissue remodelling and repair processes. It occurs in various organs, including the lung, kidney, liver and intestine, and is a key component of important pathologies, including cystic fibrosis, Crohn’s Disease and Non-Alcoholic Fatty Liver Disease. Despite the huge advances made by research in recent years, the molecular mechanisms involved in the development of fibrosis are still unclear; indeed, it would seem that different mechanisms are involved in each of the affected organs. Importantly, few effective therapeutic options are available, and only for some organs, such as the lung and kidney, with no anti-fibrotic pharmacological treatments available for the intestine or liver. The International Workshop on Liver and Gut Fibrosis – the first to take place, and endorsed by EASL – has been organised to bring together basic scientists and clinical experts working in the field with the purpose of focusing on the molecular mechanisms involved in the different types of fibrosis and determining those that are common to different organs, particularly the gut and liver. In this way, the workshop has been designed to explore options that might improve current therapeutic approaches and to identify new pharmacological targets that will relieve the burden of fibrosis for millions of patients.


We invite those of you who are interested in this topic to join us and some of the most relevant European researchers in the field here in the beautiful Mediterranean city of Valencia, at the beginning of summer, probably one of the best times of the year to visit. We look forward to seeing you.


 

  




 		  


IMPORTANT DATES    

Abstract submission:   
1 January 2020 - 16 March 2020    

Deadline for travel  grant application:  
28 February 2020   

Notification of abstract acceptance:   
30 April 2020   

 

REGISTRATION FEES    

PhD students and   
medical residents: 100.00 €   

​Postdoctoral/senior researchers   
and medical consultants: 200.00 €   
 

REGISTRATION NOW OPEN    

Registration period:   
from 1-12-2019 to 1-06-2020    
 Register      

  
     

 

 

 

 

      
     

 

 

 


Registration now open
Last places!
Registration period: 1-12-2019 until 1-06-2020
 Register
Abstracts

Abstracts can be submitted here

Organizers, sponsors, collaborators